Fecal DPP-4 serves as a biomarker for ulcerative colitis, Crohn’s disease

Fecal DPP-4 serves as a biomarker for ulcerative colitis, Crohn’s disease

Fecal dipeptidyl peptidase-4 may be used as a noninvasive biomarker in patients with inflammatory bowel disease, according to research published in Clinical and Translational Gastroenterology.“Although the diagnosis of IBD is still a challenge, over the past few years, several studies managed to identify key molecules involved in IBD pathogenesis. In this context, dipeptidyl peptidase-4 (DPP-4) emerged as a potential noninvasive biomarker of IBD activity and as a monitoring tool of the response to biological treatments,” Pedro Pinto-Lopes, MD, MSc, Centro Hospitalar UniversitárioRead More

Share on facebook
Share on twitter
Share on linkedin